Medical devices maker Smith and Nephew said that its Bioventus joint venture with Essex Woodlands is now up and running.Essex Woodlands, a specialist healthcare growth equity and venture capital firm, pitched in with Smith & Nephew (S&N) to further develop the S&N's Biologics and Clinical Therapies division.The alliance was announced at the beginning of the year but was subject to obtaining required regulatory approvals and satisfaction of other customary conditions.Essex Woodlands owns 51% of Bioventus with the rest owned by S&N.JH